RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
-13.54%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$242M
AUM Growth
+$242M
(+4.1%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
14.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$34M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $132M | 53.58% |
1,111,111
| – | – |
|
2
BioCryst Pharmaceuticals
BCRX
$1.74B
| $62.5M | 25.44% |
3,846,154
| – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $47.8M | 19.42% |
31,833,334
+22,666,667
| +247% | +$34M |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $18K | 0.01% |
3,700
| – | – |
|